The committee will be responsible for reviewing submitted abstracts and responses will be sent in early May 2019. 

Please note that if your abstract/submission is accepted presenters will be expected to register for a minimum of one day of the conference by the Early Bird Deadline of Sunday 16 June 2019.

Important Dates:
Open Abstract Submissions: Tuesday 12 February 2019
Abstract submission closes: Thursday 25 April 2019 
Registrations Open: Monday 22 April 2019 
Early Bird Deadline: Sunday 16 June 2019

Themes for abstract submission:
BPH-LUTS/Male Incontinence
Female and Functional Urology
Neurogenic
Pain/OAB
Urodynamics/Basic Sciences
Others

Instructions:
Abstracts should be submitted using the abstract template. Click here to download. Please note:

• Only online submissions will be accepted.
  
• Abstract submissions do not include authors' names and organisations/institutions.
  
• Abstracts are to be a maximum of 300 words, including references, tables and a maximum of 2 references.
  

Abstract title: should be short informative and contain the major key words - in Sentence Case (Arial, 10pt font bold and left aligned).

Other headings: should be in Arial, 10pt font, single spaced and left aligned.

Abstract should address:
1. Background and aim(s)
2. Method
3. Result(s)
4. Conclusion(s)

When using abbreviations spell out the name in full at the first mention and follow with the abbreviation in parenthesis. Abbreviations may be used in the title, provided the name in full is outlined in the body of the abstract. Capitalise the first letter of trade names.

Care should be taken to ensure high quality English expression and grammar.

Contents should include the following sections:
Introduction & Objectives: Include one or two sentences to introduce the broad topic area and provide a reason for the study. Provide a clear statement of the aims of the study. A hypothesis could be included in this section. It may also be appropriate to add references to cited literature here. References will be included in the word limit. Authors are advised to keep references to a minimum, and to use an abbreviated referencing system, i.e. First author et al., no title, year of publication, abbreviated journal title, volume, pages.

Methods: In this section information on participants (and /or subjects) should be provided. This may include the number of participants, demographic information such as age and gender as well as the method of recruitment. (ie a random sample or a convenient sample). Study inclusion and exclusion criteria should be included in this section as well as a sample size calculation if presenting a randomised clinical trial. Measures and procedures used in the study are described in this section. Descriptions of analyses appear in the methods section.

Results: The purpose of the result section is to provide a description of the main findings of the study. Reference to potential results that were unavailable at the time that the abstract was submitted will not be acceptable. Submitted abstracts must include actual results. Results should be expressed as means or medians and the spread of the results indicated as ranges, standard deviations or 95% confidence intervals as appropriate. Probability values must be included, but are not sufficient of themselves without descriptive statistics (means, etc).

Conclusions: In this section you should provide statements of interpretation and implication of findings, as well as comparison with previous literature. It should not be a simple restatement of the results.